CD1D and hematologic disorder: Moreover, in solid tumors and hematological malignancies, human and mouse CD1d-restricted iNKT cells reshape the TME by selectively eliminating CD1d-expressing protumor M2-like macrophages while preserving antitumor M1-like populations (35, 38, 39).